((3aR,9aR,10aS,10bS,Z)-9a-Methyl-3-methylene-2-oxo-2,3,3a,4,5,8,9,9a,10a,10b-decahydrooxireno[2',3':9,10]cyclodeca[1,2-b]furan-6-yl)methyl(3,5-bis(trifluoromethyl)phenyl)carbamate

ID: ALA4226062

Chembl Id: CHEMBL4226062

PubChem CID: 145969244

Max Phase: Preclinical

Molecular Formula: C24H23F6NO5

Molecular Weight: 519.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C1C(=O)O[C@@H]2[C@H]3O[C@]3(C)CC/C=C(/COC(=O)Nc3cc(C(F)(F)F)cc(C(F)(F)F)c3)CC[C@@H]12

Standard InChI:  InChI=1S/C24H23F6NO5/c1-12-17-6-5-13(4-3-7-22(2)19(36-22)18(17)35-20(12)32)11-34-21(33)31-16-9-14(23(25,26)27)8-15(10-16)24(28,29)30/h4,8-10,17-19H,1,3,5-7,11H2,2H3,(H,31,33)/b13-4-/t17-,18-,19+,22+/m0/s1

Standard InChI Key:  JVNPBSXQDQJQDR-PKCKAYTLSA-N

Alternative Forms

  1. Parent:

    ALA4226062

    ---

Associated Targets(Human)

JeKo-1 (376 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SJSA-1 (970 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-N-MC (815 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-2 (46422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.44Molecular Weight (Monoisotopic): 519.1480AlogP: 6.03#Rotatable Bonds: 3
Polar Surface Area: 77.16Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.81CX Basic pKa: CX LogP: 5.90CX LogD: 5.90
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.17Np Likeness Score: 1.22

References

1. Alwaseem H, Frisch BJ, Fasan R..  (2018)  Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis.,  26  (7): [PMID:28826596] [10.1016/j.bmc.2017.08.009]

Source